In one of the most significant consumer-goods mergers of the year, Kimberly-Clark is buying Tylenol maker Kenvue in a ...
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...
One of biggest takeovers so far this year will create a global company with annual revenues of roughly $32 billion.
US consumer goods giant Kimberly-Clark has agreed to acquire rival Kenvue in what will be one of the biggest takeovers of the ...
Kimberly-Clark's nearly $50 billion offer for Tylenol maker Kenvue is a risky bet that the world's biggest consumer market, ...
Kleenex maker Kimberly-Clark will buy Kenvue at a 46% premium, tanking its own stock by 13%. Synergies promise a decent ...
One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback